Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.76 USD | +1.37% |
|
+0.05% | +138.61% |
03:02pm | Mizuho Securities Raises Price Target on ADMA Biologics to $14 From $12, Maintains Buy Rating | MT |
17/06 | Adma Biologics Insider Sold Shares Worth $2,548,580, According to a Recent SEC Filing | MT |